Transforming growth factor-b (TGF-b) stimulation of Type I collagen gene (COL1A2) transcription involves the Smad signal transduction pathway, but the mechanisms of Smad-mediated transcriptional activation are not fully understood. We now demonstrate that the ubiquitous transcriptional coactivators p300 and CREB-binding protein (CBP) enhanced basal as well as TGF-b-or Smad3-induced COL1A2 promoter activity, and stimulated the expression of endogenous Type I collagen. The adenoviral E1A oncoprotein abrogated stimulation of COL1A2 activity in transfected ®broblasts, and reduced the basal level of collagen gene expression. This eect was due to speci®c interaction of E1A with cellular p300/CBP because (a) a mutant form of E1A defective in p300 binding failed to abrogate stimulation, and (b) forced expression of p300/CBP restored the ability of TGF-b to stimulate COL1A2 promoter activity in the presence of E1A. The eect of p300 on COL1A2 transcription appeared to be due, in part, to its intrinsic acetyltransferase activity, as stimulation induced by a histone acetyltransferasede®cient mutant p300 was substantially reduced. Transactivation of COL1A2 by p300 involved the Smad signaling pathway, as Smad4-de®cient cells failed to respond to p300, and stimulation was rescued by overexpression of Smad4. Furthermore, minimal constructs containing only the Smad-binding CAGACA element of COL1A2 were transactivated by p300 in the presence of TGF-b. These results indicate, for the ®rst time, that the multifunctional p300/CBP coactivators play a major role in Smad-dependent TGF-b stimulation of collagen gene expression in ®broblasts.
Introduction
Transforming growth factor-b (TGF-b) is a highly pleiotropic cytokine which plays a fundamental role in wound healing, development and repair. TGF-b participates in these processes by enhancing the synthesis of collagen and other components of extracellular matrix, and regulating ®broblast dierentiation, proliferation and apoptosis (Roberts and Sporn, 1990; Massague, 1998; Kawabata and Miyazono, 1999) . These cellular responses to TGF-b involve modulation of the transcription of cellular genes such as collagens, but the molecular mechanisms remain poorly understood. Recent studies have identi®ed Smad proteins as major downstream targets of activated TGF-b receptor kinases, with important roles in intracellular TGF-b signaling in vertebrates (Padgett et al., 1998; Kretzschmar and Massague, 1998) . Based on their structure and function, Smads are classi®ed into three subgroups. The pathway-restricted Smads are directly phosphorylated and activated by bone morphogenetic protein (BMP) or activin/TGF-b receptors. Smad4, representing a distinct subfamily, oligomerizes with the receptor-regulated Smads and together these complexes translocate into the nucleus where they activate the transcription of TGF-b-inducible genes (Kawabata et al., 1998) . Smad6 and Smad7 inhibit TGF-b signaling by receptor-regulated Smads.
Smads participate in TGF-b-induced transcriptional regulation by two distinct mechanisms. Smad2 and Smad3 interact directly with cis-acting regulatory elements of certain target genes via the conserved MH1 domain, thus functioning as DNA-binding factors (Feng et al., 1998; Dennler et al., 1998; Labbe et al., 1998; Chen et al., 1999) . However, regulation of other TGF-b-responsive genes involves the speci®c interaction of Smads with DNA-binding proteins and coactivators such as FAST-1 (Liu et al., 1997a; Chen et al., 1997; Zhou et al., 1998) and FAST-2 (Labbe et al., 1998; Liu et al., 1999) . We recently demonstrated that Smad3 stimulated the activity of the COL1A2 promoter in transiently transfected ®broblasts in the presence or absence of TGF-b (Chen et al., 1999) . The functional TGF-b response element of the COL1A2 promoter harbored a consensus CAGACA sequence located at 7263/7258 bp that was speci®cally recognized by Smad3 in electrophoretic mobility shift assays (Chen et al., 1999) . p300 and CBP are structurally closely related nuclear proteins, originally isolated by virtue of their ability to bind to adenoviral E1A oncoprotein and cAMP response element binding protein (CREB), respectively (Chirivia et al., 1993; . p300 and CBP have largely overlapping functions, as highlighted by the similarities in the phenotypes of p3007/7 and CBP7/7 knockout mice (Yao et al., 1998) . Therefore, in accordance with current convention,`p300/CBP' will be used here when discussing properties of p300 or CBP. These two ubiquitously expressed proteins regulate a wide range of biological responses to external stimuli, and play key roles in growth and development (Yao et al., 1998; Giles et al., 1998) . Mutation in a single CBP allele is associated with the Rubinstein-Taybi syndrome characterized by multiple developmental defects, including skeletal and craniofacial abnormalities (Petrij et al., 1995) . Mutations in the coding region of p300 have been identi®ed in several types of colorectal and gastric carcinomas, suggesting that p300/CBP could be tumor suppressor genes (Muraoka et al., 1996; Sobulo et al., 1997) . Mice lacking the p300 gene die during embryogenesis (Yao et al., 1998) . p300/CBP do not themselves interact with speci®c DNA sequences, but function as transcriptional coactivators or adapter proteins that are recruited to target promoters by sequence-speci®c DNA-binding proteins. p300/CBP interact with CREB, jun, MyoD, the STATs, p53, nuclear hormone receptors and other transcriptional factors (Giles et al., 1998 : Arany et al., 1994 . The role of p300 and CBP as coactivators for various transcription factors enables cross-talk between distinct intracellular signaling pathways. Furthermore, p300/CBP form multimeric complexes with histone acetylases such as PCAF (Yang et al., 1996) , and themselves possess intrinsic histone acetyltransferase (HAT) activity (Bannister and Kouzarides, 1996; Ogryzko et al., 1996) . Acetylation of core histones alters nucleosomal conformation, decreasing histone anity for DNA, and facilitating access of transcription factors to their recognition sites (Struhl, 1998) . Recruitment of HATs to promoters by sequencespeci®c DNA-binding factors is likely to play a key role in regulating transcription. As acetyltransferases, p300/CBP have a relatively broad range of substrate speci®city and in addition to histones can also acetylate p53, GATA-1 and erythroid Kruppel-like factor. Acetylation of these transcription factors enhances their DNA-binding and transcriptional activities (Gu and Roeder, 1997; Zhang and Beiker, 1998; Boyes et al., 1998) . In addition, p300 causes acetylation of general transcription factors such as TFIIEb (Imhof et al., 1997) .
Drosophila loss-of-function mutants of p300 display defects which closely mimic those seen in mutants lacking extracellular Dpp, the Drosophila TGF-b homolog (Waltzer and Bienz, 1999) . Indeed, CBP has been shown to bind to Drosophila MAD in vitro (Waltzer and Bienz, 1999) , and two-hybrid screens have demonstrated that CBP can physically interact with mammalian Smad2 (Topper et al, 1998) , and Smad3 in vivo (Janknecht et al., 1998) . This interaction is enhanced by TGF-b receptor-mediated phosphorylation of Smad2 or Smad3 (Feng et al., 1998; Pouponnot et al., 1998) . Furthermore, overexpression of p300/CBP was shown to enhance TGF-b-stimulated expression of p800, p3TP, A3 and other arti®cial promoter constructs in a variety of transformed cell lines (Feng et al., 1998; Topper et al., 1998; Janknecht et al., 1998; Pouponnot et al., 1998) . These observations implicate p300/CBP in Smad-mediated intracellular TGF-b signal transduction.
Smad3-dependent stimulation of COL1A2 transcription represents an important physiologic response to TGF-b. In the present report we examine the functional role of p300/CBP in regulation of COL1A2 expression in primary human ®broblasts. The results demonstrate that overexpression of p300/ CBP resulted in stimulation of endogenous Type I collagen gene expression, and further enhanced Smaddependent stimulation of COL1A2 promoter activity. Stimulation was abrogated by the E1A oncoprotein, which competed with Smad3 for a limiting amount of cellular p300/CBP. The full transcriptional response of COL1A2 to p300 required intact cellular Smad signaling, and the presence of a Smad-binding element of the COL1A2 promoter. These results establish the critical role of Smad-p300/CBP interactions in physiological regulation of collagen transcription by TGF-b.
Results

p300/CBP stimulate COL1A2 transcription and gene expression
In order to examine the functional role of p300/CBP in regulation of COL1A2 transcription, primary cultures of dermal ®broblasts were co-transfected with a p300 expression vector along with 772COL1A2/ CAT, and chloramphenicol acetyltransferase (CAT) activity was determined following a 48 h incubation. The results, shown in Figure 1a , indicated that ectopic expression of p300 caused a substantial increase in COL1A2 promoter activity, and further enhanced its stimulation induced by TGF-b. Whereas Smad3 by itself augmented promoter activity sixfold, simultaneous overexpression of p300 and Smad3 together caused a 15-fold increase, suggesting a functional interaction between p300 and Smad3 in the TGF-b signaling pathway targeting the COL1A2 promoter in ®broblasts.
Next, the eect of p300/CBP overexpression on endogenous Type I collagen gene expression in ®broblasts was examined by Northern analysis and immunoblotting. The results indicated that transient transfection of a p300 expression vector caused an increase in COL1A2 mRNA, comparable to the eects of TGF-b (Figure 1b, upper panel) . The level of cellular collagen in p300-transfected ®broblasts was also increased fourfold (Figure 1b, lower panel) . Endogenous p300 was readily detectable in unstimulated ®broblasts. and was localized predominantly in the nucleus both in the presence and absence of TGF-b (Figure 1c) . In order to determine whether TGF-b caused modulation of the level of cellular p300, endogenous p300 expression was examined in untreated and TGF-b-treated ®broblasts by immunoblotting. As shown in Figure 1d , incubation with TGF-b for 24 h caused a dose-dependent stimulation of p300 expression in these cells, with a maximal threefold increase.
Impaired stimulation of COL1A2 activity by CBP 1891 ± 2175 and HAT-deficient p300 p300/CBP can modulate the transcriptional activity of cellular genes by bridging DNA-bound transcription factors and the basal transcriptional machinery, as well as by causing acetylation of lysine residues of nucleosome histones and DNA-binding nuclear transcription factors. In order to examine the role that intrinsic HAT activity plays in p300 modulation of COL1A2 transcription, a HAT-de®cient p300 mutant was ectopically expressed in ®broblasts. As shown in Figure 1e , basal or TGF-b-induced COL1A2 promoter activity was stimulated less eectively by this mutant form of p300 than by wild-type p300, despite comparable levels of expression of the two proteins in transfected cells (inset). Stimulation of COL1A2 promoter activity by a truncated CBP mutant CBP 1891 ± 2175 , consisting of the SMAD-binding region (Janknecht et al., 1998) , was also reduced (Figure 1e ).
E1A specifically abrogates Smad-dependent stimulation of COL1A2 promoter activity
The adenoviral E1A oncoprotein can physically associate with p300/CBP and interfere with its ability to induce transcription of speci®c target genes Arany et al., 1995; Lundblad et al., 1995) . E1A is therefore a useful experimental tool to examine the requirement for p300/CBP in basal and Smad3-or TGF-b-stimulated COL1A2 transcription. Fibroblasts were transfected with vectors expressing E1A12S or its mutant E1AD2-36, along with 772COL1A2/CAT, and CAT activities were determined. The results demon-
strated that ectopic expression of E1A abrogated stimulation of the COL1A2 promoter by TGF-b or by Smad3, and suppressed even unstimulated activity ( Figure 2a ). In contrast, E1AD2-36, which lacks the Nterminal amino acids 2 ± 36 and cannot bind p300/CBP although it retains the ability to interact with Rb (Kraus et al., 1992) , did not inhibit stimulation of promoter activity; indeed, it further enhanced the response induced by TGF-b or Smad3. In order to examine the eect of E1A on Type I collagen synthesis, we used recombinant adenoviruses. Fibroblasts were infected with adenovirus expressing wild-type E1A12S or mutant E1AD2-36. These viruses express comparable levels of the E1A protein (Moran et al., 1986) . The levels of collagen in the culture media from the infected cells were determined by immunoblotting. The results showed that expression of the E1A12S in the ®broblasts resulted in a dose-dependent reduction in the secretion of collagen (Figure 2b ). Identical results were found with E1A12S in the presence of TGF-b (data not shown). In contrast, mutant E1AD2-36, which does not bind p300/CBP, had essentially no eect on secretion of collagen. No cytopathic eect was detected during the incubation period. These results further implicate p300/CBP as transcriptional coactivators with critical roles in the regulation of COL1A2 expression in primary ®broblasts.
The E1A oncoprotein targets a variety of transcription factors in addition to p300/CBP (Dyson and Harlow, 1992) . Therefore, repression of TGF-b or Smad-stimulated COL1A2 promoter activity by E1A could be due to its interaction with components of the transcription complex on the COL1A2 promoter or to sequestration or inactivation of p300/CBP. To con®rm that inhibition of COL1A2 promoter activity by E1A was due to competition for a limiting amount of cellular p300/CBP, we examined whether increasing p300 levels in the cells could reverse the repression by E1A. As shown in Figure 2c , cotransfection of p300 rescued TGF-b stimulation of COL1A2 promoter activity in ®broblasts in the presence of E1A. The ability of p300 to overcome E1A-induced repression supports the notion that p300 is required for Smaddependent stimulation of COL1A2 transcription, and that inhibition of this response by E1A involves its interaction with, or inactivation of cellular p300/CBP. As shown in Figure 2d , similar expression levels of p300 protein were detected in control and E1A-transfected ®broblasts by immunoblotting, suggesting that inhibition of COL1A2 promoter activity by E1A e Figure 1 p300 enhances Smad3-induced COL1A2 gene expression in skin ®broblasts. (a) Normal skin ®broblasts were transfected with 772 COL1A2 /CAT and expression vectors for p300, Smad3, or empty vectors. The cultures were incubated in the absence (open bars) or presence (®lled bars) of TGF-b1 (12.5 ng/ml) for 24 h, and CAT activity was determined. Transfection eciency was monitored by measuring luciferase activity of co-transfected pRL-TK. The results, normalized with protein concentration, are expressed as the means+s.d. of duplicate samples and are representative of at least three independent experiments. (b) Fibroblasts transfected with p300 or empty vector were incubated in the absence and presence of TGF-b1. Upper panel: After 24 h incubation, ®broblasts were harvested and total RNA was subjected to Northern analysis. Membranes were hybridized to human COL1A2 cDNA. Equal loading of RNA was con®rmed by rehybridization of the membranes with GAPDH cDNA, and by agarose gel electrophoresis. Lower panel: After 48 h, ®broblasts transfected with empty vector or p300 expression vector were harvested, and the level of Type I collagen in cell lysates was analysed by immunoblotting with antibody to Type I collagen. Actin was used as internal control. (c) Expression of endogenous p300. Fibroblasts were treated with TGF-b (12.5 ng/ml) for the indicated periods and were incubated with anti-p300 antibodies, as described in Materials and methods. Immuno¯uorescence was examined by confocal microscopy. Panels on right show phase contrast images of the same plates. (d) Fibroblasts were incubated with indicated concentrations of TGF-b. At the end of 24 h incubation, cells were harvested, and 12 mg aliquots of whole-cell lysates were analysed by immunoblotting with antibodies to p300 or actin. (e) Fibroblasts were transfected with p300, p300DHAT, CBP 1891 ± 2175 expression vectors or empty vector along with 772COL1A2/CAT. Cells were harvested following 24 h incubation in the absence (open bars) or presence (closed bars) of 12.5 mg/ml TGF-b1, and CAT activities were determined. Inset, Immunoblot demonstrating similar levels of wild-type and mutant p300 proteins in transfected COS-7 cells. Lane 1, vector; lane 2, p300; lane 3, p300DHAT; lane 4, CBP 1891 ± 2175
Oncogene Type I collagen gene regulation by p300/CBP AK Ghosh et al was not due to repression of the synthesis but rather to the interaction of endogenous p300 with E1A in transfected ®broblasts.
p300-induced stimulation of COL1A2 requires endogenous Smad signaling
Overexpression of p300/CBP in the ®broblasts enhanced Smad3-mediated stimulation of COL1A2 promoter activity, whereas this response was abrogated by E1A. Taken together with the previous demonstration that p300/CBP physically interacted with Smads in vivo (Feng et al., 1998; Topper et al., 1998; Pouponnot et al., 1998) , these ®ndings suggest that a functional interaction of p300 with endogenous Smad is involved in the regulation of COL1A2 transcription by TGF-b. In order to directly examine whether p300/CBP were functionally dependent on endogenous Smads, MDA-MB468 adenocarcinoma cells de®cient in Smad4 were used. Overexpression of p300 in MDA-MB468 cells, in contrast to ®broblasts, caused only minimal (35%) stimulation of 772COL1A2/CAT promoter activity (Figure 3) . Smad4 rescued the ability of p300 to induce COL1A2 transcription in Smad4-de®cient cells, resulting in a *15-fold increase in activity (Figure 3 ). These ®ndings indicate that stimulation of COL1A2 promoter activity by p300 in transfected cells required intact endogenous Smad signaling.
Smad-binding CAGACA element of COL1A2 promoter required for p300-induced stimulation p300/CBP were shown to physically interact with Smads (Feng et al., 1998; Topper et al, 1998; Janknecht et al., 1998; Pouponnot et al., 1998) . We previously demonstrated that Smad3 stimulated Type I collagen gene expression, and that endogenous Smad3 was required for TGF-b-induced stimulation of collagen transcription in ®broblasts (Chen et al., 1999; 2000) . The CAGACA element of COL1A2 promoter located at 7258/7263 bp is a speci®c recognition site for Smad3 (Chen et al., 1999) . In order to further establish the functional signi®cance of the interaction of p300 with endogenous Smad3, we asked whether the Smad3-binding CAGACA element of COL1A2 promoter was able to mediate p300 stimulation transcription. Fibroblasts were cotransfected with two deletion mutants of the COL1A2 promoter; 108COL1A2/CAT contains the sequences between 7108 bp to +58 bp, whereas 353COL1A2/CAT extends 5' to 7353 bp, and contains the CAGACA element located at 7258/7263 bp. The results demonstrated that overexpression of p300 caused ®vefold stimulation of promoter activity driven by the 7353 deletion in the presence or absence of TGF-b, whereas only a minimal (*40%) increase was observed with the 108COL1A2/CAT construct which lacks the Smad-binding CAGACA element (Figure 4a ). To further evaluate the potential role of endogenous Smad3 in p300-mediated stimulation of COL1A2 transcription, we used a heterologous reporter construct (CAGA-COL1A2/luc) containing six tandem copies of the CAGACA element of COL1A2 in front of the minimal thymidine kinase (TK) promoter (Dennler et al., 1998) . TGF-b-induced activation is speci®c and dependent on Smad3 with this luciferase reporter construct (Chen et al., 1999) . HepG2 cells were transiently transfected with the reporter construct along with the p300 expression vector. The results indicated that p300 overexpression markedly enhanced TGF-b-mediated stimulation of promoter activity, from 50% in the absence of p300 to 4threefold in the presence of p300 (Figure 4b ). Enhanced TGF-b stimulation was seen only with the CAGACA-containing construct, but not with the minimal TK promoter (Figure 4b ). By itself, p300 did not stimulate promoter activity. This is likely to be due to the low level of ligand-independent Smad3 DNA-binding in these cells, in contrast to ®broblasts (Chen et al., 1999) . Taken together, these results indicate that the Smad-binding CAGACA element of COL1A2 at 7258/7263 bp is involved in p300-mediated stimulation of COL1A2 transcription, further supporting the notion that interaction of cellular Smad with its cognate cis elements and with the p300/CBP coactivators underlies p300-mediated stimulation.
Discussion
The results described in this report establish a fundamental role for p300/CBP in the regulation of COL1A2 promoter activity and endogenous Type I collagen gene expression in human ®broblasts. p300/ CBP participate in the transcriptional regulation of cellular genes by a variety of mechanisms. p300/CBP can function as coactivators that link signal-responsive DNA-bound transcription factors to the basal transcriptional machinery (Nakajima et al., 1997) , or can modify chromatin structure by virtue of their intrinsic HAT activity, as well as their association with other histone acetyltransferases such as PCAF (Giles et al., 1998) . Increasingly recognized is the ability of p300/ CBP to acetylate non-histone proteins, including general transcription factors such as TFIIE (Imhof et al., 1997) , and sequence-speci®c DNA-binding factors (Gu and Roeder, 1997; Zhang and Beiker, 1998; Boyes et al., 1998) .
We show here that overexpression of p300/CBP markedly enhanced the Smad-dependent TGF-b stimulation of COL1A2 promoter activity in transiently transfected human ®broblasts. Furthermore, the expression of COL1A2 mRNA, and synthesis of Type I collagen, were stimulated by p300/CBP. How does TGF-b induce the coactivator function of p300/CBP in COL1A2 transcription in vivo? Most likely by increased cellular availability of activated Smad3 to interact with p300/CBP (Feng et al., 1998; Janknecht et al., 1998; Pouponnot et al., 1998) . However, p300/CBP may also be directly activated by TGF-b, particularly since its phosphorylation status has been shown to in¯uence its transcriptional coactivator function (Kitabayashi et al., 1995; Kawasaki et al., 1998) . The eect of TGF-b on the phosphorylation state and HAT activity of p300/ CBP has not been examined to date. Notably, we show here that TGF-b induced a dose-dependent increase of p300 accumulation in the ®broblasts. Taken together, these observations suggest that the activation state and relative cellular abundance of Smad3, p300/CBP, and probably additional factors implicated on collagen transcription such as Sp1 (Tamaki et al., 1995; Li et al., 1995) collectively determine the level of COL1A2 transcription in ®broblasts.
The role of p300/CBP in TGF-b-stimulated COL1A2 expression in ®broblasts is further supported by the results with E1A. The E1A oncoprotein is an adenovirus early gene product that potently stimulates cell cycle progression. E1A exerts pleiotropic eects on transcription via its interaction with broadly active cellular regulators such as members of the Rb family p107 and p130 (Ewen et al., 1991; Hannon et al., 1993) , and importantly, p300 and CBP (Feng et al., 1998; Janknecht et al., 1998; Pouponnot et al., 1998) . A recent report indicated that E1A can directly interact with, and inhibit the function of, endogenous Smad3 via its MH2 domain, thus providing an alternate mechanism for E1A repression of TGF-b-stimulated transcription (Nishihara et al., 1999) . Several TGF-bmediated cellular responses, including stimulation of junB, p15 and p21 gene transcription (Coussens et al., 1994; Datto et al., 1997) , are suppressed by E1A, and inhibition depended on the ability of E1A to bind to and inactivate critical targets of TGF-b signaling. Here, we show that wild-type E1A inhibited the Smad-dependent stimulation COL1A2 promoter activity and endogenous gene expression. In contrast, mutant E1AD2-36, defective in associating with p300/ CBP, failed to repress COL1A2 promoter activity, and indeed further enhanced this response. Endogenous levels of p300/CBP were unaected by overexpression of wild-type E1A in the ®broblasts (Figure 2d ), indicating that repression of COL1A2 transcription by E1A was not due to inhibition of p300/CBP synthesis, but rather to the association of E1A with limiting amounts of cellular p300/CBP. The present results do not allow us to determine whether this interaction inhibits COL1A2 transcription by sequestering p300/CBP, or by repressing its function (Hamamori et al., 1999) .
Smad3 and Smad4 are critical intracellular transducers of TGF-b signals in vertebrate cells. Upon ligand activation, the heteromeric complex of receptorspeci®c Smad3 and Smad4 translocate into the nucleus and bind to speci®c elements in target promoters, resulting in activation of their transcription (Heldin et al., 1997) . We and others have previously demonstrated that Smad3 transactivated the collagen promoter and enhanced their response to TGF-b in human primary ®broblasts (Vindevoghel et al., 1998; Kon et al., 1999; Chen et al., 1999) . The mechanisms that control transactivation of collagen and other cellular genes by the DNA-bound Smad complex remain poorly understood, and are likely to involve the interaction of Smads with coactivators. Several lines of evidence suggest that p300/CBP participate in Smad-mediated transcriptional regulation. Drosophila CBP loss-of-function mutations display a phenotype resembling that of dpp mutants, indicating a coactivator role for CBP in Mad signaling (Waltzer and Bienz, 1999) . Mammalian p300/CBP physically interact with endogenous Smads in a ligand-dependent manner in vivo (Feng et al., 1998; Topper et al., 1998; Janknecht et al., 1998) , and the MH2 domain and linker regions of Smads were sucient for this interaction (Pouponnot et al., 1998) . The enhanced interaction of Smad3 upon its TGF-b-induced phosphorylation with p300/CBP synergistically stimulated the transcription of target genes (Janknecht et al., 1998) .
The present results provide strong evidence that a functional interaction between p300/CBP and endogenous Smad is involved in TGF-b-stimulated collagen gene expression in vivo. p300/CBP markedly enhanced the stimulation of collagen transcription induced by overexpression of Smad3 in the ®broblasts. Wild-type E1A, but not its mutant unable to bind to p300/CBP, abrogated Smad3-induced increase in promoter activ-ity. Furthermore, in cells de®cient in Smad4, p300 was unable to stimulate COL1A2 promoter activity unless Smad4 was overexpressed. Studies with promoter deletions indicated that elimination of the CAGACA Smad recognition site of the COL1A2 promoter resulted in the loss of inducibility of this construct by p300. On the other hand, the Smad-binding sequence conferred p300 inducibility in the presence of TGF-b to an unresponsive minimal promoter in transfected cells; thus, the Smad-response element of COL1A2 also appears to be a`p300/CBP response element'.
We sought to establish whether p300/CBP exists in a stable complex with TGF-b-activated Smads in transcriptional complexes assembled on the Smad-binding element of COL1A2 in gel shift assays. In these studies, we were unable to detect p300/CBP in nuclear extracts from TGF-b-stimulated ®broblasts by supershifting with anti-p300 antibodies (data not shown). This however does not rule out the possibility that p300/ CBP interacted with DNA-bound Smads in ®broblasts stimulated by TGF-b, because the epitopes recognized by the antibody are likely to be hidden within the multimeric transcription complex.
Taken together, the present results are consistent with a model where TGF-b activation induces Smad binding to the COL1A2 promoter, as well as association with nuclear p300/CBP. This results in recruitment of these coactivators to the CAGACA Smad-binding element, and activation of transcription by the DNA-bound Smad-p300/CBP complex. Of interest is our demonstration that TGF-b stimulated the dose-dependent accumulation of endogenous p300/ CBP in ®broblasts. Given that the cellular availability of p300/CBP is rate-limiting in various ligand-induced signal transduction pathways, an increase in the amounts of coactivators available to interact with activated Smads would further enhance TGF-bstimulated transcription. In this model, E1A overexpression in the ®broblasts inhibited Smad-dependent COL1A2 transcription by binding to and sequestering cellular p300/CBP, or by decreasing its transactivation potential. Whether abrogation of stimulated collagen synthesis by E1A is bene®cial to the adenovirus comparable to its ability to inhibit IFN-g signaling, or is simply an epiphenomenon, is unknown at this time.
How does p300/CBP, recruited by activated Smad to the COL1A2 promoter, enhance transcription? Acetylation of chromatin due to intrinsic p300/CBP HAT activity could result in enhanced accessibility of the COL1A2 promoter to positively-acting DNA-binding transcription factors. Although this scenario is supported by the ®nding that transactivation by mutants of p300/CBP lacking the HAT domain was diminished (Figure 1e) , it is unlikely that histone acetylation is fully responsible for the stimulation by p300/CBP, since the histone deacetylase inhibitor NaB did not stimulate endogenous COL1A2 mRNA expression in these ®broblasts in vitro (data not shown). In light of its ability to catalyze acetylation of sequence-speci®c transcription factors and other regulatory proteins in addition to histone, it is conceivable that recruitment of p300/CBP results in acetylation of Smad3, increasing its DNA-binding and transcriptional activities. The well-known ability of p300/CBP to bridge DNA-bound proteins to the general transcription machinery may also be implicated. In light of our demonstration of the critical role of p300/CBP in Smad-dependent stimulation of collagen transcription, and the importance of this response in the pathogenesis of ®brosis, the mechanism of transcriptional activation by p300/CBP merits further investigation.
Materials and methods
Cell culture
Human dermal ®broblast cultures were established by explanting tissue specimen from neonatal foreskin, and maintained as previously described (Varga et al., 1987) . Fibroblasts were grown in Eagles' Minimal Essential Medium (EMEM) (Biowhittaker, Walkersville, MD, USA) supplemented with 10% fetal bovine serum (FBS) (GIBCO, BRL, Gaithersburg, MD, USA), 1% vitamins, 1% penicillin/ streptomycin and 2 mM L-glutamine. Primary ®broblasts at passages 4 ± 6 were studied at con¯uence. COS-7 and HepG2 cells, and MDA-MB468 breast adenocarcinoma cells that are de®cient in Smad4 (Schutte et al., 1996) were obtained from American Type Culture Collection (Rockville, MD, USA) and cultured in DMEM supplemented with 10% FBS.
Plasmids
772COL1A2/CAT, 353COL1A2/CAT and 108COL1A2/CAT (from M Trojanowska) contain sequence from 7772, 7353 and 7108 to +58 of the human COL1A2 promoter, respectively, fused to the CAT reporter gene (Ihn et al., 1997) . The CAGA-COL1A2/luc construct, which is responsive to Smad3 (Yuan W and Varga J, unpublished) was created by inserting six copies of CAGACA sequence of COL1A2 (7258/7263 bp) in front of herpes simplex virus thymidine kinase minimal promoter (TK) fused to luciferase coding region. p300 (from D Livingston) contains sequences from +1134 bp to +9046 bp of p300 in CMVb . p300 and p300DHAT (from J Boyes) contains Nterminal FLAG-tagged full-length p300 and N-terminal FLAG-tagged p300 lacking the HAT domain (amino acids 1472 ± 1522) in pCI respectively (Boyes et al., 1998) . CBP 1891 ± 2175 (from R Janknecht) contains amino acids 1891 ± 2175 of CBP (Janknecht et al., 1998) . E1A12S contains the E1A structural gene in pBC12/CMV (Raychaudhuri et al., 1991) . In E1AD2-36, amino acids 2 ± 36 of the p300-interacting domain of E1A have been deleted (Raychaudhuri et al., 1991) . pEGFP-N-FLAG-Smad3 (from H Lodish) contains N-terminal FLAG-tagged Smad3 (Liu et al., 1997b) . pRK-hMAD-4FLAG (from R Derynck) contains C-terminal FLAG-tagged human Smad4 cDNA (Zhang et al., 1996) . Recombinant wild-type E1A12S and mutant E1AD2-36 viruses contain 12S or amino acids 2 ± 36 deleted 12S cDNA in an Ad5/d1309 background respectively (Moran et al., 1986) .
Transfection and CAT assay
Subcon¯uent (75 ± 80%) cultures of dermal ®broblasts in EMEM, or MDA-MB468 adenocarcinoma cells and HepG2 cells in DMEM, were transfected by the calcium phosphate/ DNA co-precipitation method (Gorman et al., 1982) . After 18 h incubation, cells were rinsed with phosphate buered saline (PBS), allowed to recover for 3 h in EMEM with 10% FBS, and then fresh media containing 0.1% FBS and TGFb1 (from Amgen, Thousand Oaks, CA, USA) or TGF-b2 (from Celtrix, Santa Clara, CA, USA) (12.5 ng/ml) were added. These two isoforms of TGF-b consistently yielded identical results in each assay. At the end of a further 24 h incubation, cells were rinsed with PBS twice and lysates were Oncogene Type I collagen gene regulation by p300/CBP AK Ghosh et al prepared using passive lysis buer (Promega, Madison, WI, USA). Aliquots containing identical amounts of protein were used for determination of CAT activity with [ 14 C]-chloramphenicol as substrate by phase extraction, as described previously (Chen et al., 1999) . Experiments were performed in duplicates and repeated three to four times. In order to normalize for small variations in transfection eciencies, pRLTK-LUC was cotransfected in every experiment, and transfection eciency was evaluated by monitoring luciferase activity. COS-7 cells were transfected with wild-type and mutant p300 constructs using FuGene transfection reagent (Boehringer-Mannheim, Indianapolis, IN, USA), and harvested after 48 h incubation.
Virus infection
Con¯uent ®broblasts in EMEM with 10% FBS were infected with crude 293 cell lysates containing wild-type E1A12S and mutant E1AD2-36 expressing adenovirus (5 ± 25 pfu/cell). The virus was added directly to the media, and incubation continued for 48 h as described (Morozov et al., 1997) . At the end of the incubation period, the media were harvested, and the amount of secreted Type I collagen was determined.
Western blot analysis
In order to examine expression of endogenous proteins in cells transfected with p300 or E1A, cell extracts or supernatants from same cell cultures used for measuring CAT activities were immunoblotted. Equal amount of proteins from lysates of transfected ®broblasts (10 ± 15 ug) or COS-7 cells (100 ug) were electrophoresed on 4 ± 20% SDS-polyacrylamide gradient gels at 100 V at room temperature. The separated proteins were electrotransferred to PVDF membranes (Milipore, Bedford, MA, USA) at 30 V overnight at 48C. Membranes were blocked with 10% fat free dry milk, and incubated with 1 ± 2 ug/ml of primary antibodies. The antibodies to Type I collagen (Southern Biotechnology Associates Inc., Birmingham, AL, USA), p300 (C-20, which recognized only p300 but not CBP) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), FLAG epitope (Sigma Chemicals. St. Louis, MO, USA) or actin (C-2, which reacts with both a and b actin isoforms, Santa Cruz Biotechnology) were added in TBST buer for 2 h at room temperature. The membranes were then washed three times, incubated with appropriate secondary antibodies for 60 min at room temperature, washed three times and developed with ECL reagent (Amersham Life Sciences, Piscataway, NJ, USA) for 1 min and exposed on Kodak XAR5 ®lm.
Northern hybridization
Total RNA was extracted from ®broblasts using TRIZOL reagent (Life Technologies, Grand Island, NY, USA). Equal amounts of total RNA (15 mg) were separated in 1% formaldehyde agarose gels and transferred to nitrocellulose ®lters. Filters were hybridized with radiolabeled human COL1A2 (Myers et al., 1981) , or glyceraldehyde 3-phosphate dehydrogenase (GAPDH) probes, washed and exposed for 1 day.
Immunocytochemistry
The expression and intracellular localization of endogenous p300 in the presence or absence of TGF-b was studied by immunocytochemistry. For this purpose, ®broblasts (10 000 cells/well) were seeded into 8-well Lab-Tek II chamber glass slides (Nalge Nunc International, Naperville, IL, USA) with EMEM with 10% FCS. The next day, fresh media with 0.1% FCS were added. Following incubation with the indicated concentrations of TGF-b1, cells were chilled on ice 5 min, washed with ice-cold PBS, ®xed with 100% methanol at 7208C, and washed twice at room temperature with PBS. The cells were then incubated with 10 mg/ml primary antibodies (mouse anti-p300, Zymed) in TNB buer (0.1 M Tris/HCl, pH 7.5, 0.15 M NaCl, 0.5% Blocking Reagent) for 1 h. Following three washes in TNT buer (0.1 M Tris/HCl, pH 7.5, 0.15 M NaCl, 0.05% Tween-20), cells were incubated for 30 min with horseradish peroxidase-conjugated antimouse secondary antibodies (Santa Cruz) in TNB buer. After three washes in TNT buer, the cells were stained according to the manufacturer's protocol (Tyramide Signal Ampli®cation, NEN Lifescience Products, Boston, MA, USA). Immuno¯uorescence was examined by confocal microscopy.
